Cine-MRI and 31P-MRS for evaluation of myocardial energy metabolism and function following coronary artery bypass graft

Magnetic Resonance Imaging

Volumn 28, Issue 7, 2010, Pages 936-942

  Zhang, Zhuoli ^a,b   Li, Junxia ^a,c   Wu, Shengyong ^d   Liu, Ying ^a   Fan, Zhaoyang ^b   Zhou, Xiangzhi ^b   Zhao, Haitao ^a   Li, Debiao ^b   Huan, Yi ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b NORTHWESTERN UNIVERSITY   (United States)

^c BETHUNE INTERNATIONAL PEACE HOSPITAL   (China)

^d TIANJIN FIRST CENTRAL HOSPITAL   (China)

Author keywords

Cine magnetic resonance imaging; Coronary artery bypass grafting surgery; Heart function; High energy phosphate; Phosphorus 31 magnetic resonance spectroscopy

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY OBSTRUCTION; ENERGY METABOLISM; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE METABOLISM; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

EID: 77955414592     PISSN: 0730725X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mri.2010.03.040     Document Type: Article

References (23)

1. Soliman O.I., Kirschbaum S.W., van Dalen B.M., van der Zwaan H.B., Delavary B.M., Vletter W.B., et al. Accuracy and reproducibility of quantitation of left ventricular function by real-time three-dimensional echocardiography versus cardiac magnetic resonance. Am J Cardiol 2008, 102:778-783.
2. Hudsmith L.E., Neubauer S. Detection of myocardial disorders by magnetic resonance spectroscopy. Nat Clin Pract Cardiovasc Med 2008, 5(Suppl 2):S49-S56.
3. Beer M., Buchner S., Sandstede J., Viehrig M., Lipke C., Krug A., et al. (31)P-MR Spectroscopy for the evaluation of energy metabolism in intact residual myocardium after acute myocardial infarction in humans. MAGMA 2001, 13:70-75.
4. Weiss R.G., Bottomley P.A., Hardy C.J., Gerstenblith G. Regional myocardial metabolism of high-energy phosphates during isometric exercise in patients with coronary artery disease. N Engl J Med 1990, 323:1593-1600.
5. Yabe T., Mitsunami K., Okada M., Morikawa S., Inubushi T., Kinoshita M. Detection of myocardial ischemia by 31P magnetic resonance spectroscopy during handgrip exercise. Circulation 1994, 89:1709-1716.
6. Neubauer S., Krahe T., Schindler R., Horn M., Hillenbrand H., Entzeroth C., et al. 31P magnetic resonance spectroscopy in dilated cardiomyopathy and coronary artery disease. Altered cardiac high-energy phosphate metabolism in heart failure. Circulation 1992, 86:1810-1818.
7. Kalil-Filho R., de Albuquerque C.P., Weiss R.G., Mocelim A., Bellotti G., Cerri G., et al. Normal high energy phosphate ratios in "stunned" human myocardium. J Am Coll Cardiol 1997, 30:1228-1232.
8. Bottomley P.A., Wu K.C., Gerstenblith G., Schulman S.P., Steinberg A., Weiss R.G. Reduced myocardial creatine kinase flux in human myocardial infarction: an in vivo phosphorus magnetic resonance spectroscopy study. Circulation 2009, 119:1918-1924.
9. Hardy C.J., Weiss R.G., Bottomley P.A., Gerstenblith G. Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy. Am Heart J 1991, 122:795-801.
10. Bottomley P.A., Ouwerkerk R. Optimum flip-angles for exciting NMR with uncertain T1 values. Magn Reson Med 1994, 32:137-141.
11. Steinboeck P., Metzler B., Schocke M.F., Lechleitner M., Jaschke W., Pachinger M.D.O. Detection of a silent myocardial infarction with phosphor-31 two-dimensional chemical shift imaging (31P 2-D CSI). Herz 2003, 28:461-465.
12. Fragasso G., Perseghin G., De Cobelli F., Esposito A., Palloshi A., Lattuada G., et al. Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure. Eur Heart J 2006, 27:942-948.
13. Beer M., Seyfarth T., Sandstede J., Landschütz W., Lipke C., Köstler H., et al. Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with (31)P-SLOOP magnetic resonance spectroscopy. J Am Coll Cardiol 2002, 40:1267-1274.
14. Conway M.A., Bottomley P.A., Ouwerkerk R., Radda G.K., Rajagopalan B. Mitral regurgitation: impaired systolic function, eccentric hypertrophy, and increased severity are linked to lower phosphocreatine/ATP ratios in humans. Circulation 1998, 97:1716-1723.
15. Beyerbacht H.P., Lamb H.J., van Der Laarse A., Vliegen H.W., Leujes F., Hazekamp M.G., et al. Aortic valve replacement in patients with aortic valve stenosis improves myocardial metabolism and diastolic function. Radiology 2001, 219:637-643.
16. Beer M., Sandstede J., Landschütz W., Viehrig M., Harre K., Horn M., et al. Altered energy metabolism after myocardial infarction assessed by 31P-MR-spectroscopy in humans. Eur Radiol 2000, 10:1323-1328.
17. Jung W.I., Dietze G.J. 31P nuclear magnetic resonance spectroscopy: a noninvasive tool to monitor metabolic abnormalities in left ventricular hypertrophy in human. Am J Cardiol 1999, 83:19H-24H.
18. Cowie M.R., Mosterd A., Wood D.A., Deckers J.W., Poole-Wilson P.A., Sutton G.C., et al. The epidemiology of heart failure. Eur Heart J 1997, 18:208-225.
19. Passamani E., Davis K.B., Gillespie M.J., Killip T. A randomized trial of coronary artery bypass surgery: survival of patients with a low ejection fraction. N Engl J Med 1985, 312:1665-1671.
20. Allman K.C., Shaw L.J., Hachamovitch R., Udelson J.E. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. J Am Coll Cardiol 2002, 39:1151-1158.
21. Pagley P.R., Beller G.A., Watson D.D., Gimple L.W., Ragosta M. Improved outcome after coronary bypass surgery in patients with ischemic cardiomyopathy and residual myocardial viability. Circulation 1997, 96:793-800.
22. Alderman E.L., Fisher L.D., Litwin P., Kaiser G.C., Myers W.O., Maynard C., et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation 1983, 68:785-795.
23. Beanlands R.S., Nahmias C., Gordon E., Coates G., deKemp R., Firnau G., et al. The effects of beta(1)-blockade on oxidative metabolism and the metabolic cost of ventricular work in patients with left ventricular dysfunction: a double-blind, placebo-controlled, positron-emission tomography study. Circulation 2000, 102:2070-2075.